Profile picture

Doctor Mark Colin Gissler

University of Freiburg, Freiburg (Germany)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Transcriptomic profiling identifies tumor necrosis factor receptor-associated factor (TRAF)-5 expression in human atherosclerotic plaques as a predictor of future cardiovascular events
Presentation
Transcriptomic profiling identifies tumor necrosis factor receptor-associated factor (TRAF)-5 expression in human atherosclerotic plaques as a predictor of future cardiovascular events
See more
Serial lipoprotein(a) measurements reclassify cardiovascular risk and identify additional candidates for lipoprotein(a)-lowering therapy
Presentation
Serial lipoprotein(a) measurements reclassify cardiovascular risk and identify additional candidates for lipoprotein(a)-lowering therapy
See more
Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832
Presentation
Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832
See more
Macrophage expressed CD36 promotes plaque vulnerability in atherosclerosis
Presentation
Macrophage expressed CD36 promotes plaque vulnerability in atherosclerosis
See more
Tumor necrosis factor receptor-associated factor 5 (TRAF-5) deficiency exacerbates diet-induced adipose tissue inflammation and aggravates metabolic syndrome in mice
Presentation
Tumor necrosis factor receptor-associated factor 5 (TRAF-5) deficiency exacerbates diet-induced adipose tissue inflammation and aggravates metabolic syndrome in mice
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources